euferticron mattino/sera 20 fiale
four group pharma srl -
fg pharma emeflu integratore alimentare 20 compresse da 24g
four group pharma srl -
glyxambi
boehringer ingelheim international gmbh - empagliflozin, linagliptin - diabete mellito, tipo 2 - farmaci usati nel diabete - glyxambi, combinazione a dose fissa di empagliflozin e linagliptin, è indicato in adulti di età compresa tra 18 anni e anziani con diabete mellito di tipo 2:migliorare il controllo glicemico quando la metformina e/o una sulfonilurea (su) e uno dei monocomponents di glyxambi non forniscono un adeguato controllo glicemico;quando già in trattamento con la combinazione libera di empagliflozin e linagliptin.
frontline tri act spot cani da 10 kg a 20 kg (a.i.p.)
four pharma cro srl - permetrina, fipronil - permetrina - 1009.6 mg; fipronil - 135.2 mg - fipronil, combinations
frontline tri act spot cani da 20 kg a 40 kg (a.i.p.)
four pharma cro srl - permetrina, fipronil - permetrina - 2019.2 mg; fipronil - 270.4 mg - fipronil, combinations
jardiance
boehringer ingelheim international gmbh - empagliflozin - diabetes mellitus, type 2; heart failure; renal insufficiency, chronic - farmaci usati nel diabete - type 2 diabetes mellitusjardiance is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered in addition to other medicinal products for the treatment of diabetesfor study results with respect to combinations of therapies, effects on glycaemic control, and cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 e 5. of the annex. heart failurejardiance is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseasejardiance is indicated in adults for the treatment of chronic kidney disease.
cisatracurio accordpharma
accord healthcare, s.l.u. - cisatracurio - cisatracurio
evrysdi
roche registration gmbh - risdiplam - atrofia muscolare, spinale - altri farmaci per i disturbi del sistema muscolo-scheletrico - evrysdi is indicated for the treatment of 5q spinal muscular atrophy (sma) in patients with a clinical diagnosis of sma type 1, type 2 or type 3 or with one to four smn2 copies.
four-spur torque
tp orthodontics inc. - dispositivi per ortodonzia - altri